Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety data

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 913f519d0e83ebef-LAX IP: 116.62.10.13 UTC time: 2025-02-18T16:15:57+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4